 | • レポートコード：QY20ST-06937 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のモノクローナル抗体無菌注射薬市場について種類別（In Vivoプロダクションドラッグ、In Vitroプロダクションドラッグ）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・モノクローナル抗体無菌注射薬市場の概要 ・世界の主要地域別モノクローナル抗体無菌注射薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のモノクローナル抗体無菌注射薬市場規模2015-2026：種類別（In Vivoプロダクションドラッグ、In Vitroプロダクションドラッグ） ・世界のモノクローナル抗体無菌注射薬市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・モノクローナル抗体無菌注射薬の北米市場規模2015-2020 ・モノクローナル抗体無菌注射薬のヨーロッパ市場規模2015-2020 ・モノクローナル抗体無菌注射薬の中国市場規模2015-2020 ・モノクローナル抗体無菌注射薬の日本市場規模2015-2020 ・モノクローナル抗体無菌注射薬の東南アジア市場規模2015-2020 ・モノクローナル抗体無菌注射薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・モノクローナル抗体無菌注射薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・モノクローナル抗体無菌注射薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Monoclonal Antibodies Sterile Injectable Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Monoclonal Antibodies Sterile Injectable Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Monoclonal Antibodies Sterile Injectable Drugs industry.
Based on our recent survey, we have several different scenarios about the Monoclonal Antibodies Sterile Injectable Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Monoclonal Antibodies Sterile Injectable Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Monoclonal Antibodies Sterile Injectable Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Monoclonal Antibodies Sterile Injectable Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Monoclonal Antibodies Sterile Injectable Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Monoclonal Antibodies Sterile Injectable Drugs market. The report also includes nautical information, where it shows Monoclonal Antibodies Sterile Injectable Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Monoclonal Antibodies Sterile Injectable Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Monoclonal Antibodies Sterile Injectable Drugs market.
Geographical Analysis:
Based on region, the global Monoclonal Antibodies Sterile Injectable Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Monoclonal Antibodies Sterile Injectable Drugs market are
Merck
Pfizer
Abbott
GlaxoSmithKline
AstraZeneca
Novartis
Bayer
Amgen
Bristol Myers Squibb
Johnson&Johnson
Roche
Sanofi
Segment by Type
In Vivo Production Drugs
In Vitro Production Drugs
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Monoclonal Antibodies Sterile Injectable Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Monoclonal Antibodies Sterile Injectable Drugs market.
• The market share of the global Monoclonal Antibodies Sterile Injectable Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Monoclonal Antibodies Sterile Injectable Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Monoclonal Antibodies Sterile Injectable Drugs market.
1 Monoclonal Antibodies Sterile Injectable Drugs Market Overview
1.1 Monoclonal Antibodies Sterile Injectable Drugs Product Scope
1.2 Monoclonal Antibodies Sterile Injectable Drugs Segment by Type
1.2.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2020-2026)
1.2.2 In Vivo Production Drugs
1.2.3 In Vitro Production Drugs
1.3 Monoclonal Antibodies Sterile Injectable Drugs Segment by Application
1.3.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Monoclonal Antibodies Sterile Injectable Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Monoclonal Antibodies Sterile Injectable Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Monoclonal Antibodies Sterile Injectable Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Monoclonal Antibodies Sterile Injectable Drugs Industry
1.5.1.1 Monoclonal Antibodies Sterile Injectable Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Monoclonal Antibodies Sterile Injectable Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Monoclonal Antibodies Sterile Injectable Drugs Players to Combat Covid-19 Impact
2 Monoclonal Antibodies Sterile Injectable Drugs Estimate and Forecast by Region
2.1 Global Monoclonal Antibodies Sterile Injectable Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Monoclonal Antibodies Sterile Injectable Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Monoclonal Antibodies Sterile Injectable Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Monoclonal Antibodies Sterile Injectable Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Monoclonal Antibodies Sterile Injectable Drugs Estimates and Projections (2015-2026)
2.4.3 China Monoclonal Antibodies Sterile Injectable Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Monoclonal Antibodies Sterile Injectable Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Estimates and Projections (2015-2026)
2.4.6 India Monoclonal Antibodies Sterile Injectable Drugs Estimates and Projections (2015-2026)
3 Global Monoclonal Antibodies Sterile Injectable Drugs Competition Landscape by Players
3.1 Global Top Monoclonal Antibodies Sterile Injectable Drugs Players by Sales (2015-2020)
3.2 Global Top Monoclonal Antibodies Sterile Injectable Drugs Players by Revenue (2015-2020)
3.3 Global Monoclonal Antibodies Sterile Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibodies Sterile Injectable Drugs as of 2019)
3.4 Global Monoclonal Antibodies Sterile Injectable Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Monoclonal Antibodies Sterile Injectable Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Monoclonal Antibodies Sterile Injectable Drugs Players (Opinion Leaders)
4 Global Monoclonal Antibodies Sterile Injectable Drugs Market Size by Type
4.1 Global Monoclonal Antibodies Sterile Injectable Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Monoclonal Antibodies Sterile Injectable Drugs Price by Type (2014-2020)
4.2 Global Monoclonal Antibodies Sterile Injectable Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Monoclonal Antibodies Sterile Injectable Drugs Price Forecast by Type (2021-2026)
5 Global Monoclonal Antibodies Sterile Injectable Drugs Market Size by Application
5.1 Global Monoclonal Antibodies Sterile Injectable Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Monoclonal Antibodies Sterile Injectable Drugs Price by Application (2015-2020)
5.2 Global Monoclonal Antibodies Sterile Injectable Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Monoclonal Antibodies Sterile Injectable Drugs Price Forecast by Application (2021-2026)
3 North America Monoclonal Antibodies Sterile Injectable Drugs Market Facts & Figures
3.2 North America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
3.3 North America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
3.4 North America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
4 Europe Monoclonal Antibodies Sterile Injectable Drugs Market Facts & Figures
4.2 Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
5 China Monoclonal Antibodies Sterile Injectable Drugs Market Facts & Figures
5.2 China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
5.3 China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
5.4 China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
6 Japan Monoclonal Antibodies Sterile Injectable Drugs Market Facts & Figures
6.2 Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Market Facts & Figures
7.2 Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
8 India Monoclonal Antibodies Sterile Injectable Drugs Market Facts & Figures
8.2 India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
8.3 India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
8.4 India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Monoclonal Antibodies Sterile Injectable Drugs Business
12.1 Merck
12.1.1 Merck Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.1.2 Merck Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.1.3 Merck Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.2.2 Pfizer Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.2.3 Pfizer Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Abbott
12.3.1 Abbott Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.3.2 Abbott Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.3.3 Abbott Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Abbott Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.3.5 Abbott Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.4.2 GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.4.3 GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.5.2 AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.5.3 AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Novartis
12.6.1 Novartis Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.6.2 Novartis Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.6.3 Novartis Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.6.5 Novartis Recent Development
12.7 Bayer
12.7.1 Bayer Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.7.2 Bayer Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.7.3 Bayer Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bayer Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.7.5 Bayer Recent Development
12.8 Amgen
12.8.1 Amgen Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.8.2 Amgen Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.8.3 Amgen Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Amgen Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.8.5 Amgen Recent Development
12.9 Bristol Myers Squibb
12.9.1 Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.9.2 Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.9.3 Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.9.5 Bristol Myers Squibb Recent Development
12.10 Johnson&Johnson
12.10.1 Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.10.2 Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.10.3 Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.10.5 Johnson&Johnson Recent Development
12.11 Roche
12.11.1 Roche Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.11.2 Roche Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.11.3 Roche Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Roche Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.11.5 Roche Recent Development
12.12 Sanofi
12.12.1 Sanofi Monoclonal Antibodies Sterile Injectable Drugs Corporation Information
12.12.2 Sanofi Monoclonal Antibodies Sterile Injectable Drugs Business Overview and Total Revenue
12.12.3 Sanofi Monoclonal Antibodies Sterile Injectable Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sanofi Monoclonal Antibodies Sterile Injectable Drugs Products Offered
12.12.5 Sanofi Recent Development
13 Monoclonal Antibodies Sterile Injectable Drugs Manufacturing Cost Analysis
13.1 Monoclonal Antibodies Sterile Injectable Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Monoclonal Antibodies Sterile Injectable Drugs
13.4 Monoclonal Antibodies Sterile Injectable Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Monoclonal Antibodies Sterile Injectable Drugs Distributors List
14.3 Monoclonal Antibodies Sterile Injectable Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Monoclonal Antibodies Sterile Injectable Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Monoclonal Antibodies Sterile Injectable Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Monoclonal Antibodies Sterile Injectable Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Monoclonal Antibodies Sterile Injectable Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Share by Region (2015-2020)
Table 13. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Monoclonal Antibodies Sterile Injectable Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Share by Company (2015-2020)
Table 19. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Share by Company (2015-2020)
Table 21. Global Monoclonal Antibodies Sterile Injectable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibodies Sterile Injectable Drugs as of 2019)
Table 22. Global Monoclonal Antibodies Sterile Injectable Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Monoclonal Antibodies Sterile Injectable Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Monoclonal Antibodies Sterile Injectable Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Monoclonal Antibodies Sterile Injectable Drugs Players
Table 27. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Share by Type (2015-2020)
Table 29. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Monoclonal Antibodies Sterile Injectable Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Share by Type (2021-2026)
Table 32. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Share by Type (2021-2026)
Table 34. Global Monoclonal Antibodies Sterile Injectable Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Share by Application (2015-2020)
Table 37. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Monoclonal Antibodies Sterile Injectable Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Share by Application (2021-2026)
Table 41. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Share by Application (2021-2026)
Table 43. Global Monoclonal Antibodies Sterile Injectable Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 56. China Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
Table 58. China Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 60. China Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 74. India Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company (2015-2020)
Table 76. India Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2015-2020)
Table 78. India Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Monoclonal Antibodies Sterile Injectable Drugs Product
Table 84. Merck Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Monoclonal Antibodies Sterile Injectable Drugs Product
Table 89. Pfizer Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Abbott Monoclonal Antibodies Sterile Injectable Drugs Product
Table 94. Abbott Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Product
Table 99. GlaxoSmithKline Recent Development
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Product
Table 104. AstraZeneca Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Novartis Monoclonal Antibodies Sterile Injectable Drugs Product
Table 109. Novartis Recent Development
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Bayer Monoclonal Antibodies Sterile Injectable Drugs Product
Table 114. Bayer Recent Development
Table 115. Amgen Corporation Information
Table 116. Amgen Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Amgen Description and Business Overview
Table 118. Amgen Monoclonal Antibodies Sterile Injectable Drugs Product
Table 119. Amgen Recent Development
Table 120. Bristol Myers Squibb Corporation Information
Table 121. Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Bristol Myers Squibb Description and Business Overview
Table 123. Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Product
Table 124. Bristol Myers Squibb Recent Development
Table 125. Johnson&Johnson Corporation Information
Table 126. Johnson&Johnson Description and Business Overview
Table 127. Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Product
Table 129. Johnson&Johnson Recent Development
Table 130. Roche Corporation Information
Table 131. Roche Description and Business Overview
Table 132. Roche Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Roche Monoclonal Antibodies Sterile Injectable Drugs Product
Table 134. Roche Recent Development
Table . Sanofi Corporation Information
Table . Sanofi Description and Business Overview
Table . Sanofi Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Sanofi Monoclonal Antibodies Sterile Injectable Drugs Product
Table . Sanofi Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Monoclonal Antibodies Sterile Injectable Drugs Distributors List
Table 143. Monoclonal Antibodies Sterile Injectable Drugs Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibodies Sterile Injectable Drugs Product Picture
Figure 2. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Monoclonal Antibodies Sterile Injectable Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Monoclonal Antibodies Sterile Injectable Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Monoclonal Antibodies Sterile Injectable Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Monoclonal Antibodies Sterile Injectable Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Monoclonal Antibodies Sterile Injectable Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Monoclonal Antibodies Sterile Injectable Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Monoclonal Antibodies Sterile Injectable Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Monoclonal Antibodies Sterile Injectable Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Monoclonal Antibodies Sterile Injectable Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Monoclonal Antibodies Sterile Injectable Drugs Players Market Share by Revenue in Monoclonal Antibodies Sterile Injectable Drugs 2015 & 2019
Figure 27. Monoclonal Antibodies Sterile Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2019
Figure 33. United States Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2019
Figure 34. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company in 2019
Figure 35. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2019
Figure 36. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application in 2019
Figure 37. China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company in 2019
Figure 38. China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2019
Figure 39. China Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application in 2019
Figure 40. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company in 2019
Figure 41. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2019
Figure 42. Japan Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application in 2019
Figure 46. India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Company in 2019
Figure 47. India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2019
Figure 48. India Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application in 2019
Figure 49. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Johnson&Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Monoclonal Antibodies Sterile Injectable Drugs
Figure 63. Manufacturing Process Analysis of Monoclonal Antibodies Sterile Injectable Drugs
Figure 64. Monoclonal Antibodies Sterile Injectable Drugs Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
VEGF阻害薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The VEGF Inhibitor Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- VEGF / VEGFR阻害薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The VEGF/VEGFR Inhibitor Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 抗利尿薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antidiuretic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antidiuretic Drugs market …
- 抗体医薬品の世界市場レポート2020 Market Analysis and Insights: Global Antibody Drugs Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019…
- 抗がん剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anticancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 99610 million by 2025, from USD 86710 million in 2019. The Anticancer Drugs mark…